I was always bullish on ARC 520 / ARC 521. I was gutted when the F$#@$#@ FDA shut it down.
Now they're back with ARO-HBV which is mostly based on the same tech, and a clinical trial is starting: https://clinicaltrials.gov/ct2/show/record/NCT03365947
Is anyone else enthused by this?